The Ageing Soma, Screening and All-Cause Mortality
Paul Pharoah is Professor of Cancer Epidemiology at the University of Cambridge, where he leads research on the molecular pathology of breast and ovarian cancer […]
Five minutes with: Dr Mona Saraiya
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
Finding the optimal HPV test for primary screening and triage in Latin America
In this blog, we speak to Dr Maribel Almonte Pacheco, Prevention and Implementation Group Head at IARC. Dr Almonte is the chief investigator on the […]
Over 99.5% of young women survive following a diagnosis of IA cervical cancer
The earliest stage of cervical cancer (known as micro-invasive or stage IA) is treated with minimally-invasive fertility-preserving surgery, often as an outpatient. In fact, very […]
Best of BEST3: An interview with Rebecca Fitzgerald, Chief Investigator
In this post, we interview Rebecca Fitzgerald, chief investigator for the BEST3 trial. Her work at the MRC Cancer Unit focuses on the early detection […]
Best of BEST3: An interview with Irene Debiram-Beecham, clinical coordinator
In this post, we interview Irene Debiram-Beecham, clinical coordinator for the BEST3 trial. Irene is a Senior Research Sister in Professor Rebecca’s Fitzgerald’s group and […]
Breast screening for women in their 40s – what are we waiting for?
A friend of mine in her late 40s has just been diagnosed with breast cancer. Fortunately, she spotted it early and it sounds as if […]
Vaccine hesitancy and disease prevention – It’s not just coronavirus which stands to lose
In this post Rose Brade, International Policy Advisor at Cancer Research UK provides her personal experiences with vaccine hesitancy and the implications for cervical cancer […]
Best of BEST3: a Q&A with Beth Muldrew, Clinical Project Manager
In this blog, we interview Beth Muldrew, Clinical Project Manager for the BEST3 trial. Beth successfully managed the project from start-up to conclusion, working across […]
Best of BEST3: A (not so) hard pill to swallow- an overview of BEST3 & the Cytosponge
The results of the BEST3 trial have just been published and the findings have exceeded even our most optimistic expectations. This trial showed that the […]
Is mammography screening still worthwhile? The results of a review provide some answers…
Amanda Dibden is a statistician at Queen Mary University of London. Here she highlights the main results from her recently published worldwide review and meta-analysis […]